Chimerix (CMRX) Q1 2022 Earnings Call Transcript

Chimerix (CMRX) Q1 2022 Earnings Call Transcript

One, to announce the sale of TEMBEXA to Emergent Biosolutions, and one, announcing our first quarter operating operations. Before we begin, I would like to remind you that the statements made on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties, and other factors.